Guidance

Evidence-based recommendations on maximal cytoreductive surgery for advanced ovarian cancer. This involves removing all or almost all visible cancerous tissue. More tissue is removed than with standard surgery. The aim is to improve outcomes for people with advanced ovarian cancer.

Is this guidance up to date?

Next review: this guidance will be reviewed if there is new evidence or safety concerns.

Guidance development process

How we develop NICE interventional procedures guidance

This guidance replaces NICE interventional procedures guidance on ultra-radical (extensive) surgery for advanced ovarian cancer (IPG470).

Endorsing bodies

This interventional procedures guidance is endorsed by Healthcare Improvement Scotland as required by the Health and Social Care Act (2012).

  • National Institute for Health and Care Excellence (NICE)